Abstract
Confidence intervals of proposed individual bioequivalence metrics are difficult to determine in closed form because their stochastic distributions are unknown. In this article, it is shown that, with slightly modified weights, the Relative Individual Risk (RIR) moment-based scaled statistic for individual bioequivalence that was presented by Schall and Williams has an exact noncentral Fisherʼns F distribution with noncentrality parameter given by a scaled squared difference in formulations means. This can be approximated by a central F with adjusted degrees of freedom from which it follows that an upper (1-α) confidence bound for RIR is given by \(UL = \frac{{(\widehat{RIR} + 1)}}{{F_{\alpha ,v,df_{ER} } }} - 1\) where is the least square estimate of RIR; df ER is the degrees of freedom associated with the reference intrasubject variance estimate, ν is the subject-by-formulation degrees of freedom adjusted for noncentrality and α is the significance level. Individual bioequivalence is concluded if UL does not exceed the regulatory limit. The performance of this confidence interval was investigated by comparing its experimental bioequivalence rate to that of the unweighted metric under known parameter situations through simulations of two formulations in a fully replicated study design. Results showed that the proposed metric is slightly less biased and more precise than the unweighted metric.
Similar content being viewed by others
REFERENCES
R. Schall and R. L. Williams. Towards a practical strategy for assessing individual bioequivalence. J. Pharmacokin. Biopharm. 24:133–148 (1996).
S. Anderson and W. W. Hauck. Consideration of individual bioequivalence. J. Pharmacokin. Biopharm. 18:259–273 (1990).
S. Anderson and W. W. Hauck. Measuring switchability and prescribability: when is average bioequivalence sufficient? J. Pharmacokin. Biopharm. 22:551–564 (1994).
R. Schall and H. G. Luus. On population and individual bioequivalence. Stat. Med. 12:1109–1124 (1993).
L. B. Sheiner. Bioequivalence revisited. Statist. Med. 11:1777–1788 (1992).
G. Ekbohm and H. Melander. The subject-by-formulation interaction as a criterion of interchangeability of drugs. Biometrics 45:1249–1254 (1990).
L. Endrenyi. A simple approach for the evaluation of individual bioequivalence. Drug Inform. J. 29:847–855 (1995).
D. J. Holder and F. Hsuan. Moment-based criteria for determining bioequivalence. Biometrika 80:835–846 (1993).
H. Scheffé. The Analysis of Variance, Wiley, New York (1959).
B. Efron and R. J. Tibshirani. An Introduction to the Bootstrap, Chapman and Hall, New York, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimanani, E.K., Potvin, D. A Parametric Confidence Interval for a Moment-Based Scaled Criterion for Individual Bioequivalence. J Pharmacokinet Pharmacodyn 25, 595–614 (1997). https://doi.org/10.1023/A:1025717414526
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1025717414526